文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症监护病房中的社区获得性肺炎克雷伯菌肺炎:一项多中心回顾性研究

Community-acquired Klebsiella pneumoniae pneumonia in ICU: a multicenter retrospective study.
PubMed 文献 · Ann Intensive Care · 2024-04-30
一句话结论与肺炎链球菌社区获得性肺炎相比,肺炎克雷伯菌社区获得性肺炎的院内死亡率更高(59% vs 17%)、死亡更早(中位26.9小时),即使抗生素治疗充分。

这项在法国7个ICU开展的2015—2019年多中心回顾性研究,纳入27例肺炎克雷伯菌社区获得性肺炎(KP-CAP)和81例肺炎链球菌社区获得性肺炎(SP-CAP)进行配对比较。KP-CAP院内死亡率为59%(16例),SP-CAP为17%(14例,p<0.001),且KP-CAP从入院到死亡的中位时间为26.9小时。KP-CAP与多器官衰竭(93% vs 42%)、弥散性血管内凝血(12% vs 1.3%)、脓毒性休克(入ICU时乳酸中位数4.60 vs 2.90 mmol/L)及肾衰竭(KDIGO-3:87% vs 44%)更高发生率相关。酗酒是唯一被识别的KP-CAP易感因素,入ICU时病情严重程度(KP-CAP高2倍)是唯一与死亡率相关的因素。作者认为这些发现应提高临床医生对重症社区获得性肺炎此微生物病因的警惕。

要点

  • KP-CAP院内死亡率为59%(16例),SP-CAP为17%(14例,p<0.001),即使抗生素治疗充分。
  • KP-CAP从入院到死亡的中位时间为26.9小时(IQR 5.75-44小时),死亡更早。
  • KP-CAP与多器官衰竭(93% vs 42%,p<0.001)、弥散性血管内凝血(12% vs 1.3%,p=0.046)、脓毒性休克(入ICU时乳酸中位数4.60 vs 2.90 mmol/L,p=0.030)、肾衰竭KDIGO-3(87% vs 44%,p<0.001)更高发生率相关。
  • 酗酒是唯一被识别的KP-CAP易感因素;多因素分析中,入ICU时病情严重程度(KP-CAP高2倍)是唯一与死亡率相关的因素。

适用人群与场景

  • 2015—2019年法国7个ICU收治的社区获得性肺炎成人患者,比较KP-CAP与SP-CAP;每例KP-CAP按同一中心、同一6个月时间窗匹配3例SP-CAP。

红旗征与不能漏的情况

  • KP-CAP可能快速进展至死亡,中位时间26.9小时(IQR 5.75-44小时),即使抗生素治疗充分。
  • KP-CAP更常合并多器官衰竭(93%)、弥散性血管内凝血(12%)、脓毒性休克(入ICU时乳酸中位数4.60 mmol/L)和肾衰竭KDIGO-3(87%)。

研究设计与关键结果

  • 多中心回顾性研究,纳入27例KP-CAP和81例SP-CAP;主要终点为院内死亡率,KP-CAP为59%(16例),SP-CAP为17%(14例,p<0.001)。
  • KP-CAP从入院到死亡的中位时间为26.9小时(IQR 5.75-44小时)。
  • KP-CAP与更高的多器官衰竭发生率相关(93% vs 42%,p<0.001)、弥散性血管内凝血(12% vs 1.3%,p=0.046)、脓毒性休克(入ICU时乳酸中位数4.60 vs 2.90 mmol/L,p=0.030)、肾衰竭KDIGO-3(87% vs 44%,p<0.001)。
  • 酗酒是唯一被识别的KP-CAP易感因素;多因素分析中,入ICU时病情严重程度(KP-CAP高2倍)是唯一与死亡率相关的因素。

证据类型、等级与局限

  • 证据类型:多中心回顾性研究。
  • 局限:原文未报告局限性;作者指出需要前瞻性研究来确认这些结果并设计改善此类感染预后的策略。

对床旁实践的改变

  • 作者认为这些发现应提高参与重症社区获得性肺炎管理的临床医生对该微生物病因的警惕。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Alongside the recent worldwide expansion of hypervirulent Klebsiella pneumoniae (KP) infections, the available literature regarding cases of community acquired pneumonias (KP-CAP) remains scarce but reports a strikingly high and early mortality. We performed a retrospective multicenter study (7 ICU in France) between 2015 and 2019, comparing prognosis and severity of KP-CAP versus Streptococcus pneumoniae - CAP (SP-CAP).

METHODS: For each KP-CAP, three SP-CAP admitted in ICUs within the same center and within the same 6-month window were selected. When available, KP strains were studied, and bacterial virulence was genetically assessed for virulence factors. The primary outcome was in-hospital mortality. Associations between clinical outcomes and type of infection were tested using univariate and multivariate logistic regressions, adjusted for pairing variables.

RESULTS: Twenty-seven KP-CAP and 81 SP-CAP were included. Respective in-hospital mortality rates were 59% (n = 16) and 17% (n = 14, p < 0.001), despite adequate antibiotic therapy. KP-CAP median time from admission to death was 26.9 h [IQR 5.75-44 h] and were significantly associated with higher rates of multiple organ failures (93% vs. 42%, p < 0.001), disseminated intravascular coagulation (12% vs. 1.3%, p = 0.046), septic shock (median lactate on ICU admission 4.60 vs. 2.90 mmol/L, p = 0.030) and kidney failure (KDIGO-3: 87% vs. 44%, p < 0.001). Interestingly, alcoholism was the only identified predisposing factor of KP-CAP. Severity on ICU admission (2-fold higher for KP-CAP) was the only factor associated with mortality in a multivariate analysis.

CONCLUSION: We described a strong association between KP-CAP infection and higher and earlier mortality when compared to SP-CAP. Moreover, alcoholism was the sole predisposing factor associated with KP-CAP infection. These findings should raise awareness of clinicians involved in the management of severe CAP about this microbiological etiology. Future prospective studies are needed to confirm these results and to design strategies to improve the prognosis of such infections.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Grosjean V, Gressens SB, Pham T, et al. Community-acquired Klebsiella pneumoniae pneumonia in ICU: a multicenter retrospective study. Ann Intensive Care. 2024. PMID: 38687409. doi:10.1186/s13613-024-01269-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。